We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.33 | 3.70% | 9.25 | 9.00 | 9.50 | 9.30 | 9.25 | 9.30 | 180,216 | 09:12:40 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.27M | -11.94M | -0.0129 | -7.17 | 85.82M |
Date | Subject | Author | Discuss |
---|---|---|---|
11/2/2019 13:35 | Bob - Which is your 'Worst performing stoch' ??? | the real lozan | |
11/2/2019 13:23 | Yep timing is everything. Angle sat on my watch list for well over a year (possibly 2) before I bought and now it's one of my best performing stocks. | bermudashorts | |
11/2/2019 13:11 | escape, A shrewd tactic, long as: 1) You can spot the bottom 2) You are sure it's a cycle (rather than a pogo stick) | gazza | |
11/2/2019 12:54 | Im getting interested! After spending 15 years in Angle plc, INVESTMENT, for no result. I do rather like buying shares at the bottom of their cycle and taking a gamble. It can reap very handsome rewards indeed. | escapetohome | |
11/2/2019 12:10 | Gazza, so true :-) ATB | oldnotwise | |
11/2/2019 11:43 | ONW, understand what you are saying. My thinking is, there is only so much cake ("the Market" for cancer treatment). You either keep it all for yourself or you share it. If you are licensing your technology you are agreeing to share it. What I am saying is, you can't always have your cake and eat it. | gazza | |
11/2/2019 11:29 | Ground CONtrol to major Tom - Put YOUR helmet on | the real lozan | |
11/2/2019 11:25 | Panama7 It is beginning to look like my last buy at 6.8p was premature.Good job it was only 50k and should just be more patient lol | ivyspivey | |
11/2/2019 11:20 | One trade going through this morning for 6p, ouch, wonder if C7 can confirm if that was a buy or sell? To be honest though, this will struggle to hold the 6's this week and the 5's are a very realistic scenario, wouldn't want to be in this come Friday | wanderer1210_0 | |
11/2/2019 11:06 | As the REAL ISSUE of FUNDING remains -the real lozan - 06 Feb 2019 - 'non dilutive injection of Capital' ??? Last week I posted = "So - How do *WE ALL* explain = "We have £10 mil 'in the bank' " "We have £8.7 mil 'in the bank' " When we CLEARLY ..have NOT "FUNDING is NOT an ISSUE here" When it CLEARLY...WAS, and STILL IS . Some folks seem to want to 'brush misleading DANGERS under the carpet' And Bring M F F F 'censor/censure' here to prevent others speaking their minds. . This is NOT the forum that has been responsible for HUGE LOSSES.. that some appear to 'enjoy'." ....AS per RNS, Cash End OCT 2018 WAS £7.6 mil ....As per RNS' Cash burn WAS running at £3.24 mil per 6 months OR circa {call it} = £125,000 a WEEK RNS {interims} WAS 14 Weeks ago....14 x £125,000 = £1,750,000 MEANING = CASH could now be LESS than £6 mil...With NO TRIALS STARTED More or less = exactly the situation a YEAR AGO /// before the last FUND RAISING 6.5 p....Oh DEAR | the real lozan | |
11/2/2019 10:59 | Hi Gazza, Can't disagree wiyh the basic premise of your comment, but although a licensing deal does give the buyer rights over the use of an asset, the ownership of that asset remains with the company, and the licensing agreement has a value of its own should the company decide to sell that part of the business. the upside is that the company granting the licence retains the asset whilst creating value (income stream) which enhances the attractiveness of the Shares (identifiable and quantifiable income stream for shareholders) and therefore the shareholder value becomes "valuable" in the context of future cashflow/dividend projections. So I understand your comments but I'm sure any self respecting accountant could put what I'm struggling to say more succinctly! BTW this point does bear comparison with ARM Holdings, so be warned.... :-) AIMO ATB | oldnotwise | |
11/2/2019 10:58 | Gazza.Personally would settle for a deal for future dilution which is standard way these bios grow. Yes you may achieve more value by progressing the science but SCLP can’t do this under its own steam and never intends to commercialise itself so better to sacrifice some of future value to achieve current funding requirements. The main mistake I think SCLP made was not securing enough funding in the last round to ensure they could complete at least one of trial data outcomes. It may be they announce an alternative source of non dilutive capital and know from chat at AGM they are looking at many sources and although they could not predict delay to IND it is part of BOD responsibility to cope with these events by having appropriate contingency plans. Based in the history of SCLP you would have felt contingency planning would be high up on the list of priority’s | ivyspivey | |
11/2/2019 10:35 | Surely the only truly "non-dilutive" capital would be a "donation". Any sale, commercial deal, licensing deal will have an associated element of dilution don't you think? Companies putting cash in will want either a stock holding or a share of future profits. | gazza | |
11/2/2019 09:51 | ONW - IMO a 'non dilutive injection of Capital' of any size would be likely to give the share price a boost. If only . . . . . | torquayfan | |
11/2/2019 09:38 | I keep seeing posts that "will move us" up in share price FWIW I reckon one of two things willdo it. 1 A significant non dilutive injection of Capital 2 Significant Data from Trial/s. So short term there seems likely to be only one source of upward momentum. Let's hope we see it... AIMO ATB | oldnotwise | |
11/2/2019 00:11 | Well done Chelsea. One right between the eyes for TurkeyFan.......GTF is the message. Will we see Scancell lose 6 this week, there is a good chance. | terror | |
09/2/2019 14:20 | anyway time for something more interesting six nations | inanaco | |
09/2/2019 14:19 | and Ruck """"The barriers to informed debate are lying, misquoting and making wild assumptions. Half of what he posts is utter jibberish. On occasions, he doesn’t even understand what he himself has written as demonstrated by my discussion with him last night. """ LOL ... everyone on that LSE BB .. "" can see you are a Space Cadet"" nobody supports you even TF did not intervene I have no idea why YOU consider yourself smart ! | inanaco | |
09/2/2019 14:17 | LOL .. Bermuda will at least attempt a science debate and get into a serious discussion Gazza and Co .. Nothing .. just the usual !! If i was Bermuda i would be embarrassed by your support and the way you go about it .. | inanaco | |
09/2/2019 14:11 | Inan, Sadly that's all you've got - name calling. | gazza | |
09/2/2019 13:56 | out come the Space Cadets pmsl "protect the failed post" at all costs | inanaco | |
09/2/2019 13:52 | Bermuda, I have on numerous occasions tried to have a sensible, adult conversation with Inanaco and each time failed spectacularly. The barriers to informed debate are lying, misquoting and making wild assumptions. Half of what he posts is utter jibberish. On occasions, he doesn't even understand what he himself has written as demonstrated by my discussion with him last night.I honestly believe he actually know too much about the science. Nowhere near enough to make him an expert or enough to underwrite his investment decisions but just enough to make him BELIEVE he does. This makes him a danger to himself and others. The pilgrimage to the monument of "scientific knowledge" has caused the loss of common sense and any sense of reality. The sound bites emanating from him are mostly meaningless. What does "Scancell is proven" actually mean? Absolutely nothing! Does anyone with a modicum of common sense really think we would be sat here at sub 7p if ANYTHING associated with Scancell were "proven"? | gazza |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions